Does a GLP-1 lower testosterone in women with PCOS?
If you live with PCOS, the number on a lab report is rarely the thing that keeps you up at night. The acne that will not quit, the hair showing up where you do not want it, the stubble of an unpredictable cycle: those are the daily realities, and they are often driven by high androgens. So when one of these medications enters the conversation, the honest question underneath "will it help me lose weight" is usually this one: will it actually touch the hormone that is causing all of this? Here is what the research says, in plain terms, without hype.
Key takeaways
Dr. Linda's take
I want to be straight with you, because you have probably been promised a lot already. These medications are not hormone erasers. They do not walk up to your ovary and switch off testosterone. What the evidence keeps showing is quieter and more believable than that: as weight and insulin resistance improve, the androgen picture tends to soften too. That can mean the acne calms, the cycle becomes a little more predictable, and you feel more like yourself. It is a meaningful shift, not a magic one.
These medicines are approved for type 2 diabetes and for long-term weight management, and using them for PCOS specifically sits outside those approvals, so this is a decision a clinician makes with you one person at a time. The most reliable way to know whether the tradeoffs make sense for your body, your labs, and your goals is a real conversation, and our two-minute quiz is a low-pressure place to start that.
What does high testosterone actually do in PCOS?
The reason androgens matter so much here is that they are behind the symptoms women with PCOS feel most. Interventions for PCOS can include metformin, combined oral contraceptive pills, spironolactone, and local treatments for hirsutism and acne. That list exists because excess androgen shows up on the skin and in the cycle, not just on a lab slip. When people ask whether something "helps PCOS," what they usually mean is whether it helps the hirsutism, the acne, and the irregular periods that androgen excess drives. So the fair test of any medication is not only the scale. It is whether it nudges that underlying hormone.
Does a GLP-1 lower testosterone in women with PCOS?
Short answer: yes, modestly, and mostly through the metabolic door rather than a direct hormonal one. In a 2025 systematic review and network meta-analysis, GLP-1 receptor agonists showed significant improvement in free androgen index, free testosterone, androstenedione, and sex hormone binding globulin levels. A separate meta-analysis limited to women with PCOS and obesity looked specifically at the hormone numbers. Compared with placebo, GLP-1 receptor agonist use was associated with a significant reduction in total testosterone levels. In women with PCOS and obesity, GLP-1 receptor agonists can reduce body mass index and waist circumference and improve hyperinsulinism and hyperandrogenism.
Read those findings together and the mechanism comes into focus. The androgen benefit rides alongside the weight and insulin benefit. That is why the honest framing is indirect and modest, not targeted androgen therapy. If you want the fuller picture on one specific medicine, our overview of semaglutide and PCOS walks through what is known.
Is a GLP-1 plus metformin better for androgens than either alone?
This is where the data gets genuinely interesting. In a network meta-analysis of antidiabetic drugs, GLP-1 receptor agonists in combination with metformin appeared preferable for improving hyperandrogenemia. A 2026 network meta-analysis found that the combination of metformin plus a GLP-1 receptor agonist produced the greatest decrease in total testosterone and free androgen index among the drugs compared. In overweight women with PCOS, adding metformin to a GLP-1 receptor agonist was associated with higher sex hormone binding globulin and lower free testosterone than the GLP-1 receptor agonist alone.
The specific medicine studied most in PCOS has often been exenatide. In a meta-analysis of women with PCOS, the reduction in total testosterone was more significant after treatment with exenatide than after treatment with metformin. Exenatide combined with metformin was more effective than metformin alone in improving sex hormone binding globulin and reducing free androgen index, weight, and waist circumference. If you are weighing the two medicines against each other, our guide on whether metformin or a newer medicine is better for PCOS lays out the tradeoffs.
What are the honest limits here?
This matters as much as the good news. In the 2026 network meta-analysis, metformin combined with GLP-1 receptor agonists most effectively attenuated hyperandrogenism, but at the price of greater gastrointestinal intolerance. Nausea and other digestive effects are common enough that they are worth planning for, and you can read more in our notes on the side effects to expect with these medicines. Just as important, researchers note that the low certainty of much of the evidence underscores the need for large, long-term randomized trials to confirm these findings. In plain language: the direction of the effect looks consistent, but the field is still young, the studies are small, and no one should promise you a fixed result.
Frequently asked questions
Is a GLP-1 a cure for PCOS?
No. PCOS is a chronic condition, and no current medication resets it permanently. It may help shift the metabolic and androgen picture while you take it, and recently these medicines have shown promising results in PCOS management. Think of it as management, not a finish line.
Will lower testosterone mean less acne and less unwanted hair?
Often the hope is that softening androgens softens the skin and hair symptoms too, since those are androgen driven in PCOS. The hormone-lab improvements are documented, but how much your own skin or hair changes varies from person to person, and dedicated treatments for hirsutism and acne still have a role.
How much does it lower testosterone?
The effect is best described as modest. Across analyses, testosterone and free androgen index move in the right direction rather than dropping dramatically, and the biggest movements tend to appear when the two medicines are paired. Your labs, your starting point, and your response all shape the real result.
Is this an approved PCOS treatment?
These medicines are approved for type 2 diabetes and for long-term weight management, not for PCOS itself, so any use for PCOS is a case-by-case clinical decision made with your own prescriber. That is exactly the kind of question a licensed clinician should answer for your situation, not an article.
References
1. Journal of the Endocrine Society (2019). Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls. PubMed PMID 31384717. https://pubmed.ncbi.nlm.nih.gov/31384717/ (Accessed 2026-07-19).
2. Diabetology & metabolic syndrome (2025). Expanding therapeutic horizons: glucagon-like peptide-1 receptor agonists and sodium glucose transporter-2 inhibitors in poly cystic ovarian syndrome: a comprehensive review including systematic review and network meta-analysis of randomized clinical trials. PubMed PMID 40410888. https://pubmed.ncbi.nlm.nih.gov/40410888/ (Accessed 2026-07-19).
3. Journal of diabetes and its complications (2024). The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: A meta-analysis of randomized controlled trials. PubMed PMID 39178623. https://pubmed.ncbi.nlm.nih.gov/39178623/ (Accessed 2026-07-19).
4. Drugs (2022). The Effect of Oral Antidiabetic Drugs on Improving the Endocrine and Metabolic States in Women with Polycystic Ovary Syndrome: A Systematic Review and Network Meta-analysis. PubMed PMID 36129662. https://pubmed.ncbi.nlm.nih.gov/36129662/ (Accessed 2026-07-19).
5. BMC endocrine disorders (2023). Comparison of exenatide alone or combined with metformin versus metformin in the treatment of polycystic ovaries: a systematic review and meta-analysis. PubMed PMID 37974132. https://pubmed.ncbi.nlm.nih.gov/37974132/ (Accessed 2026-07-19).
6. Journal of ovarian research (2026). The efficacy and safety of novel antidiabetic agents in polycystic ovary syndrome: a network meta-analysis. PubMed PMID 41862977. https://pubmed.ncbi.nlm.nih.gov/41862977/ (Accessed 2026-07-19).
7. The Journal of clinical endocrinology and metabolism (2020). Insulin Sensitizers for Improving the Endocrine and Metabolic Profile in Overweight Women With PCOS. PubMed PMID 32490533. https://pubmed.ncbi.nlm.nih.gov/32490533/ (Accessed 2026-07-19).
---
*This article is general education and is not medical advice. It cannot tell you what is right for your body. Talk with a licensed clinician about your own situation.*
*Written and clinically reviewed by Dr. Linda Moleon, MD. Last reviewed 2026-07-19.*
Keep reading
How much weight can you lose on retatrutide?
Retatrutide is investigational, but its phase 2 trial is striking · the highest 12-mg dose cut body weight a mean 24.2% at 48 weeks. Dr. Linda lays out the real numbers, the context against approved options, and why phase 2 results can still shift.
Can you take a GLP-1 if you have hypothyroidism?
Treated hypothyroidism is not a reason to rule out a GLP-1, and the boxed warning is about a rare thyroid cancer, not an underactive gland · but because these medicines slow gastric emptying, levothyroxine absorption is worth monitoring with a clinician.
Can a GLP-1 lower heart disease risk after menopause?
The SELECT trial found semaglutide lowered major cardiovascular events by 20% in people with established heart disease and obesity without diabetes · but it was not a menopause trial, so Dr. Linda explains where the evidence is solid and where it is extrapolated.
Were Black and Latina women included in GLP-1 weight-loss trials?
Black and Latina women were enrolled in the major semaglutide and tirzepatide weight-loss trials, and subgroup analyses found the medicines worked across race and ethnicity · but non-white participants were under-represented relative to disease burden.
How much muscle do you lose on a GLP-1, and can you get it back?
Some of the weight lost on a GLP-1 is muscle, not just fat. Dr. Linda Moleon, MD on how much lean mass the trials show, whether it comes back after stopping, and the two things that actually protect it.
Does Florida heat affect how you store your GLP-1?
Florida heat is real, and your GLP-1 pen has rules. Dr. Linda Moleon, MD lays out the exact refrigerator range, room-temperature limits, and discard windows straight from the Wegovy and Zepbound FDA labels, so your medication still works when you need it.